company logo
Efficacious vaccine for respiratory viruses.
Basic Information
Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. In addition, the technology allows for very rapid, large-scale, and low-cost production of vaccines that could potentially be used to protect people when there is a pandemic. Mynvax, which was incubated at the Indian Institute of Science, was founded in2017 by Raghavan Varadarajan and Gautham Nadig.
Legal Name
:
Mynvax Private Limited
Headquarters
:
Bengaluru, Karnataka, India
Founding Date
:
2017
No. of Employees
:
21 to 40
Core Team
:
1.  
Gautham Nadig
Co-Founder and Executive Director
2.  
Raghavan Varadarajan
Co-Founder and Director
Funding

Total Funding

$4.1M

Investors
:
1.  
Ajith Sukumaran
2.  
Accel